Mynaric Announces Receipt of Deficiency Letter from Nasdaq
1. Mynaric received a deficiency letter from Nasdaq over bid price compliance. 2. The company failed to maintain a minimum bid price of $1.00.
1. Mynaric received a deficiency letter from Nasdaq over bid price compliance. 2. The company failed to maintain a minimum bid price of $1.00.
Non-compliance with Nasdaq rules can lead to delisting, impacting investor confidence.
Failure to comply with listing requirements is significant for investor sentiment and stock performance.
Immediate market reaction expected due to compliance issues, affecting current trading.